ArticleScientific reports2025

Cirsiliol alleviates experimental inflammatory bowel disease via restoration of intestinal barrier integrity and inhibition of NF-κB and MAPK pathways.

Juan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.